1st Circuit Reverses Summary Judgment In Celexa/Lexapro Off-Label Suits
BOSTON — The First Circuit U.S. Court of Appeals on Jan. 30 reversed summary judgment in an antidepressant off-label lawsuit but affirmed a trial court’s denial of class certification due to...To view the full article, register now.
Already a subscriber? Click here to view full article